IMMUNODEFICIENCIES
Clinical trials for IMMUNODEFICIENCIES explained in plain language.
Never miss a new study
Get alerted when new IMMUNODEFICIENCIES trials appear
Sign up with your email to follow new studies for IMMUNODEFICIENCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New IVIG therapy aims to shield patients with rare immune disorders
Disease control Recruiting nowThis study tests a medicine called V-IMMUNE® in about 50 people aged 2 and older who have a weak immune system (primary immunodeficiency). Participants will receive V-IMMUNE® infusions every three weeks for a year. The goal is to see if it safely reduces serious infections and im…
Matched conditions: IMMUNODEFICIENCIES
Phase: PHASE3 • Sponsor: On Pharma Importadora, Exportadora e Distribuidora de Medicamentos LTDA. • Aim: Disease control
Last updated May 16, 2026 22:27 UTC
-
New hope for kids with rare blood diseases: expanded stem cell access
Disease control Recruiting nowThis program provides stem cell transplants for up to 100 children and young adults with life-threatening blood disorders, such as leukemia or immune deficiencies, who do not have a matched sibling donor. The approach uses a special technique to remove certain immune cells from t…
Matched conditions: IMMUNODEFICIENCIES
Phase: EARLY_PHASE1 • Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated May 11, 2026 20:46 UTC
-
NIH launches massive blood study to unlock HIV's secrets
Knowledge-focused Recruiting nowThis study aims to learn more about how HIV infects cells and affects the immune system by collecting blood and other biological samples from up to 2,419 adults, both with and without HIV. Researchers will compare these samples to better understand the virus and related immune de…
Matched conditions: IMMUNODEFICIENCIES
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated May 08, 2026 12:01 UTC